Can an Alzheimer’s Drug Help HIV+ People with Cognitive Dysfunction?
CROI 2012 Paper #482. Rivastigmine for the Treatment of HIV-associated Neurocognitive Disorders: A Randomized, Double-blind, Placebo-controlled, Crossover Pilot Study The prevalence of HIV-associated neurocognitive disorders (HAND) remains high despite successful antiretroviral therapy. This study performed by researchers from the HIV Swiss Cohort aimed at looking at the effect of rivastigmine on HAND in patients with …
Can an Alzheimer’s Drug Help HIV+ People with Cognitive Dysfunction? Read More »